{"id":389230,"date":"2023-05-19T00:00:00","date_gmt":"2023-05-19T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/codrta0001-biopharma-daiichi-sankyo-therapeutic-portfolio-2022\/"},"modified":"2026-05-07T11:16:50","modified_gmt":"2026-05-07T11:16:50","slug":"codrta0001-biopharma-daiichi-sankyo-therapeutic-portfolio-2022","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/codrta0001-biopharma-daiichi-sankyo-therapeutic-portfolio-2022\/","title":{"rendered":"Daiichi-Sankyo | Therapeutic Portfolio | 2022"},"content":{"rendered":"<p>The therapeutic portfolio includes the descriptive content of the company&#8217;s therapy area such as franchise profile, sales analysis, pipeline analysis, deal and key events.<\/p>\n","protected":false},"template":"","class_list":["post-389230","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-date-975"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/389230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/389230\/revisions"}],"predecessor-version":[{"id":392361,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/389230\/revisions\/392361"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=389230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}